Related Experiment Video
Updated: Jul 5, 2026
11:14
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Metal-5-Fluorouracil-histamine complexes: solution, structural, and antitumour studies.
Sadhna Tyagi1, Sukh Mahendra Singh, Sujan Gencaslan
1Department of Chemistry Indian Institute of Technology Roorkee Roorkee 247 667 India.
Metal-Based Drugs
|May 14, 2008
Summary
This study investigated metal complexes of 5-fluorouracil (5FU) and histamine (Hm) with various metal ions. Ternary complexes showed enhanced stability and some demonstrated significant antitumour activity in mice.
Area of Science:
- Coordination Chemistry
- Medicinal Chemistry
- Materials Science
Background:
- Metal complexes play a crucial role in biological systems and drug development.
- 5-fluorouracil (5FU) is a widely used chemotherapeutic agent.
- Histamine (Hm) is a biogenic amine with diverse physiological functions.
Purpose of the Study:
- To investigate the interaction of Co(II), Ni(II), Cu(II), Zn(II), and Cd(II) metal ions with 5FU and Hm.
- To determine the stability of binary and ternary complexes.
- To evaluate the antitumour activity of synthesized metal complexes.
Main Methods:
- Solution studies using pH-metry at constant temperature and ionic strength.
- Species distribution curves generated using the BEST computer program.
- Characterization of solid complexes using physico-chemical methods.
- In vivo and in vitro antitumour activity testing on Dalton's lymphoma and Sarcoma-180 models.
Main Results:
- Ternary complexes exhibited greater stability than binary complexes (positive DeltalogK).
- Mixed metal complexes were successfully synthesized and characterized.
- Some synthesized complexes displayed notable antitumour activity against tested cancer models.
Conclusions:
- The study successfully synthesized and characterized novel metal complexes with potential therapeutic applications.
- Enhanced stability of ternary complexes suggests improved drug delivery or efficacy.
- The observed antitumour activity warrants further investigation for drug development.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...